{
    "organizations": [],
    "uuid": "45074a1c76e9b83403d2d1bd0e4be6e7e759c369",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/valeant-pharm-in-results/valeant-pharma-reports-quarterly-loss-to-change-name-to-bausch-health-idUSL3N1SF4FS",
    "ord_in_thread": 0,
    "title": "Valeant Pharma reports quarterly loss, to change name to Bausch Health",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Valeant Pharmaceuticals International Inc reported first-quarter loss compared with a year-ago profit and said on Tuesday it would change its name to Bausch Health Companies Inc.\nNet loss attributable to the company was at $2.69 billion, or $7.68 per share, in the quarter ended March 31, compared with a profit of $628 million, or $1.79 per share, a year earlier.\nTotal revenues fell 5.4 percent to $1.96 billion.\nReporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur\n ",
    "published": "2018-05-08T19:10:00.000+03:00",
    "crawled": "2018-05-09T12:19:11.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "valeant",
        "pharmaceutical",
        "international",
        "inc",
        "reported",
        "loss",
        "compared",
        "profit",
        "said",
        "tuesday",
        "would",
        "change",
        "name",
        "bausch",
        "health",
        "company",
        "net",
        "loss",
        "attributable",
        "company",
        "billion",
        "per",
        "share",
        "quarter",
        "ended",
        "march",
        "compared",
        "profit",
        "million",
        "per",
        "share",
        "year",
        "earlier",
        "total",
        "revenue",
        "fell",
        "percent",
        "billion",
        "reporting",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "arun",
        "koyyur"
    ]
}